A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).
McAllister-Williams RH, Goudie N, Azim L, Bartle V, Berger M, Butcher C, Chadwick T, Clare E, Courtney P, Dixon L, Duffelen N, Fouweather T, Gann W, Geddes J, Gupta S, Hall B, Helter T, Hindmarch P, Holstein EM, Lawrence W, Mawson P, McKinnon I, Milne A, Molloy A, Moore A, Morriss R, Nakulan A, Simon J, Smith D, Stokes-Crossley B, Stokes PR, Swain A, Taiwo A, Walmsley Z, Weetman C, Young AH, Watson S.
McAllister-Williams RH, et al. Among authors: taiwo a.
J Psychopharmacol. 2025 Feb;39(2):106-120. doi: 10.1177/02698811241309622. Epub 2025 Jan 20.
J Psychopharmacol. 2025.
PMID: 39829389
Free PMC article.
Clinical Trial.